JTA-004

N/A

Report date: 2022/11/05 13:05:42
NME

Base Information

Drug NameJTA-004
Drug Alias Namea novel off-the-shelf protein solution(Bone Therapeutics Sa)JTA-004
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHyaluronic acid replacements
TargetsHyaluronic acid
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumPoland +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBone Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesBone Therapeutics Sa
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A